Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 79, Issue 7

Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta. No Access

Abstract

The soluble vaccinia virus-encoded protein B18R inhibits the antiviral activity and cellular binding of the type I interferons (IFN)-α, - and -ω of different mammalian species. Recently, a novel type IIFN was detected in pigs and classified as a member of a distinct IFN family designated IFN-λ. Our study aimed to determine if the structural properties of this shortest (149 residues long) type I IFN allow its interaction with the type I IFN-binding protein B18R. Experiments using bovine (MDBK) cells demonstrated that B18R neutralized the antiviral activity of porcine IFN-λ with high efficiency. Preincubation of B18R with radiolabelled IFN-λ specifically inhibited binding of IFN to bovine cells. These data indicate that the overall conformation of the novel IFN-λ might be similar to that of other type I IFNs.

  • Published Online:
© Society for General Microbiology 1998
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-7-1647
1998-07-01
2025-01-25
Loading full text...

Full text loading...

References

  1. Alcamí A., Smith G. L. 1992; A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153–167
     [Google Scholar]
  2. Colamonici O. R., Domanski P., Sweitzer S. M., Larner A., Buller L. M. L. 1995; Vaccinia virus B18R gene encodes a type I interferonbinding protein that blocks interferon alpha transmembrane signaling. Journal of Biological Chemistry 270:15974–15978
     [Google Scholar]
  3. Kontsek P. 1994; Human type I interferons: structure and function. Acta Virologica 38:345–360
     [Google Scholar]
  4. Kontsek P., BoreckN L., Kontseková E., Máčiková I., Kolcunová A., Novák M., Krchňá V. 1991; Mapping of two immunodominant structures in human interferon alpha 2c and their role in binding to cells 2. Molecular Immunology 28:1289–1297
     [Google Scholar]
  5. Lefevre F., Boulay V. 1993; A novel and atypical type one interferon gene expressed by trophoblast during early pregnancy. Journal of Biological Chemistry 268:19760–19768
     [Google Scholar]
  6. Liptáková H., Kontseková E., Alcamí A., Smith G. L., Kontsek P. 1997; Analysis of an interaction between the soluble vaccinia virus- coded type I interferon (IFN)-receptor and human IFN-alpha 1 and IFN- alpha 2. Virology 232:86–90
     [Google Scholar]
  7. Lundgren E., Langer J. A. 1997; Nomenclature of interferon receptors and interferon-delta. Journal of Interferon and Cytokine Research 17:315–316
     [Google Scholar]
  8. Niu P.-D., Lefevre F., Mege D., La Bonnardiere C. 1995; Atypical porcine type I interferon. Biochemical and biological characterization of the recombinant protein expressed in insect cells. European Journal of Biochemistry 230:200–206
     [Google Scholar]
  9. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. 1987; Interferons and their actions. Annual Review of Biochemistry 56:727–777
     [Google Scholar]
  10. Symons J. A., Alcamí A., Smith G. L. 1995; Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551–560
     [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-79-7-1647
Loading
Vaccinia virus protein B18R inhibits the activity and cellular binding of the novel type interferon-delta.
J. Gen. Virol. 79, 1647 (1998); https://doi.org/10.1099/0022-1317-79-7-1647
/content/journal/jgv/10.1099/0022-1317-79-7-1647
/content/journal/jgv/10.1099/0022-1317-79-7-1647
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error